These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 31965287

  • 1. Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection.
    Luo Q, Liu Y, Zhao H, Guo P, Wang Q, Li W, Li G, Wu B.
    World J Urol; 2020 Nov; 38(11):2849-2856. PubMed ID: 31965287
    [Abstract] [Full Text] [Related]

  • 2. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B, Li H, Zhang C, Yang K, Qiao B, Zhang Z, Xu Y.
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [Abstract] [Full Text] [Related]

  • 3. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S, Otto W, Denzinger S, Wieland WF, Burger M, Stöhr R, Link S, Hofstädter F, Hartmann A.
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [Abstract] [Full Text] [Related]

  • 4. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G, Yu J, Song H, Zhu S, Sun L, Shang Z, Niu Y.
    BMC Cancer; 2017 Aug 08; 17(1):530. PubMed ID: 28789622
    [Abstract] [Full Text] [Related]

  • 5. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.
    J Urol; 2009 Dec 08; 182(6):2625-30. PubMed ID: 19836779
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul 08; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of histological discordance between transurethral resection and radical cystectomy.
    Matsuda A, Taoka R, Miki J, Saito R, Fukuokaya W, Hatakeyama S, Kawahara T, Fujii Y, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Iio H, Yasue K, Abe T, Nakanishi S, Matsumura M, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Matsui Y, Japanese Urological Oncology Group.
    BJU Int; 2024 Aug 08; 134(2):207-218. PubMed ID: 38344879
    [Abstract] [Full Text] [Related]

  • 8. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.
    J Urol; 2008 Nov 08; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [Abstract] [Full Text] [Related]

  • 9. Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.
    Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ, Gonzalgo ML.
    Urol Oncol; 2012 Nov 08; 30(4):428-33. PubMed ID: 21396836
    [Abstract] [Full Text] [Related]

  • 10. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.
    Abufaraj M, Shariat SF, Foerster B, Pozo C, Moschini M, D'Andrea D, Mathieu R, Susani M, Czech AK, Karakiewicz PI, Seebacher V.
    World J Urol; 2018 Feb 08; 36(2):231-240. PubMed ID: 29127452
    [Abstract] [Full Text] [Related]

  • 11. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Minato A, Noguchi H, Tomisaki I, Fukuda A, Kubo T, Nakayama T, Fujimoto N.
    Cancer Control; 2018 Feb 08; 25(1):1073274818800269. PubMed ID: 30213195
    [Abstract] [Full Text] [Related]

  • 12. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec 08; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 13. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
    Ge P, Wang ZC, Yu X, Lin J, He Q.
    BMC Urol; 2015 May 30; 15():46. PubMed ID: 26025446
    [Abstract] [Full Text] [Related]

  • 14. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
    Su JS, Arima K, Hasegawa M, Franco OE, Umeda Y, Yanagawa M, Sugimura Y, Kawamura J.
    Int J Urol; 2004 Feb 30; 11(2):74-82. PubMed ID: 14706010
    [Abstract] [Full Text] [Related]

  • 15. Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer.
    Otto W, Rubenwolf PC, Burger M, Fritsche HM, Rößler W, May M, Hartmann A, Hofstädter F, Wieland WF, Denzinger S.
    BMC Cancer; 2012 Oct 08; 12():459. PubMed ID: 23043286
    [Abstract] [Full Text] [Related]

  • 16. The Significance of Squamous Histology on Clinical Outcomes and PD-L1 Expression in Bladder Cancer.
    Gordetsky JB, Montgomery KW, Giannico GA, Rais-Bahrami S, Thapa P, Boorjian S, Frank I, Cheville J.
    Int J Surg Pathol; 2022 Feb 08; 30(1):6-14. PubMed ID: 34180731
    [Abstract] [Full Text] [Related]

  • 17. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD, Logan JE, Sills V, Chin AI.
    World J Urol; 2014 Apr 08; 32(2):385-91. PubMed ID: 23756991
    [Abstract] [Full Text] [Related]

  • 18. Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis.
    Wang JK, Boorjian SA, Cheville JC, Kim SP, Tarrell RF, Thapa P, Frank I.
    World J Urol; 2012 Dec 08; 30(6):801-6. PubMed ID: 23132611
    [Abstract] [Full Text] [Related]

  • 19. Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis.
    Zhao G, Wang C, Tang Y, Liu X, Liu Z, Li G, Mei Y.
    Sci Rep; 2019 Mar 29; 9(1):5323. PubMed ID: 30926888
    [Abstract] [Full Text] [Related]

  • 20. Lymphovascular invasion predicts poor prognosis in high-grade pT1 bladder cancer patients who underwent transurethral resection in one piece.
    Ukai R, Hashimoto K, Nakayama H, Iwamoto T.
    Jpn J Clin Oncol; 2017 May 01; 47(5):447-452. PubMed ID: 28184446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.